Red X iconGreen tick iconYellow tick icon
The University of Otago is launching a new brand. Find out more

Keating JP, Manning S, Dennett E and Studd R. Excision of the seminal vesicles for locally advanced and recurrent rectal and sigmoid cancer. ANZ journal of surgery. 2017;87:688-691.

Danielson KM, Rubio R, Abderazzaq F, Das S and Wang YE. High Throughput Sequencing of Extracellular RNA from Human Plasma. PLOS ONE. 2017;12:e0164644.

Sarfati D, Gurney J, Lim BT, Bagheri N, Simpson A, Koea J and Dennett E. Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival. Asia-Pacific journal of clinical oncology. 2016;12:e47-56.

Firth MJ, Sharples KJ, Hinder VA, Macapagal J, Sarfati D, Derrett SL, Hill AG, Brown C, Reid PM, Lawrenson RA, Atmore C, Keating JP, Jeffery M, Secker AH, De Groot C, Jackson CG and Findlay MP. Methods of a national colorectal cancer cohort study: the PIPER Project. The New Zealand medical journal. 2016;129:25-36.

Freedman JE, Gerstein M, Mick E, Rozowsky J, Levy D, Kitchen R, Das S, Shah R, Danielson K, Beaulieu L, Navarro FCP, Wang Y, Galeev TR, Holman A, Kwong RY, Murthy V, Tanriverdi SE, Koupenova M, Mikhalev E and Tanriverdi K. Diverse human extracellular RNAs are widely detected in human plasma. Nature Communications. 2016;7:11106.

Dew K, Stubbe M, Signal L, Stairmand J, Dennett E, Koea J, Simpson A, Sarfati D, Cunningham C, Batten L, Ellison-Loschmann L, Barton J and Holdaway M. Cancer care decision making in multidisciplinary meetings. Qualitative health research. 2015;25:397-407.

Christopher Jackson KS, Melissa Firth, Victoria Hinder, Mark Jeffery, John Keating, Adrian, Secker, Sarah Derrett, Carol Atmore, Dale Bramley, Charles De Groot, Wendy Stevens, Diana Sarfati, Charis Brown, Andrew Hill, Papaarangi Reid, Ross Lawrenson, Michael Findlay. The PIPER Project: An Internal Examination of Colorectal Cancer Management in New Zealand. 2015.

Blakely T, Collinson L, Kvizhinadze G, Nair N, Foster R, Dennett E and Sarfati D. Cancer care coordinators in stage III colon cancer: a cost-utility analysis. BMC health services research. 2015;15:306.

Laurent LC, Danielson K et al., and Gould S. Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles. 2015;4:26533.

Sarfati D, Gurney J, Stanley J, Salmond C, Crampton P, Dennett E, Koea J and Pearce N. Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. Journal of clinical epidemiology. 2014;67:586-95.

Wheeler BR, Reddy SK, Kenwright D, Keating JP. Treating Pseudomyxoma Peritonei Without Heated Intraperitoneal Chemotherapy – A First Look in New Zealand. NZMJ. 2014;118:31-39.

Gurney J, Sarfati D, Stanley J, Dennett E, Johnson C, Koea J, Simpson A and Studd R. Unstaged cancer in a population-based registry: prevalence, predictors and patient prognosis. Cancer Epidemiol. 2013;37:498-504.

Swart EM, Sarfati D, Cunningham R, Dennett E, Signal V, Gurney J and Stanley J. Ethnicity and rectal cancer management in New Zealand. The New Zealand medical journal. 2013;126:42-52.

Shi H, Hayes MT, Kirana C, Miller RJ, Keating JP, Stubbs RS. Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Human Pathology. 2013;44:1089-97.

Shah AB, Sarfati D, Blakely T, Atkinson J and Dennett ER. Trends in colorectal cancer incidence rates in New Zealand, 1981-2004. ANZ journal of surgery. 2012;82:258-64.

Shi H, Hayes M, Kirana C, Keating J, McCartney-Coxon D, Stubbs R. TUFM is a potential new prognostic indicator for colorectal carcinoma. Pathology 2012;44: 506–512.

Chandra Kirana, Hongjun Shi, Emma Laing, Kylie Hood, Rose Miller, Peter Bethwaite, John Keating, T William Jordan, Mark Hayes, Richard Stubbs. Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays. International journal of proteomics. 01/2012; 2012:245819.

Gunawardene AR, Corfe BM and Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. International journal of experimental pathology. 2011;92:219-31.

Harper SJ, McEwen AR and Dennett ER. Immunohistochemical testing for colon cancer--what do New Zealand surgeons know? The New Zealand medical journal. 2010;123:35-40.

Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, Dennett E, Cormack D, Cunningham R, Dew K, McCreanor T and Kawachi I. Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. Journal of epidemiology and community health. 2010;64:117-23.

Cunningham R, Sarfati D, Hill S, Dennett E and O'Donnell A. Colon cancer management in New Zealand: 1996-2003. The New Zealand medical journal. 2009;122:51-60.

Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, Cormack D and Dew K. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC cancer. 2009;9:116.

Memon S, Keating JP, Cooke HS and Dennett ER. A study into external rectal anatomy: improving patient selection for radiotherapy for rectal cancer. Diseases of the colon and rectum. 2009;52:87-90.

Rajaratnam SG and Dennett ER. Development of metachronous neoplasms after colorectal cancer resection: absence of synchronous neoplasms predicts a lower risk. The New Zealand medical journal. 2009;122:61-6.

Sheikh AA, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A, Prime W, Crnogorac-Jurcevic T, Lemoine NR and Costello E. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics. 2007;7:1929-40.

Simpson GS, Smith R, Sutton P, Shekouh A, McFaul C, Johnson M and Vimalachandran D. The aetiology of delay to commencement of adjuvant chemotherapy following colorectal resection. International journal of surgical oncology. 2014;2014:670212.

Carne PW, Frye JN, Kennedy-Smith A, Keating J, Merrie A, Dennett E and Frizelle FA. Local invasion of the bladder with colorectal cancers: surgical management and patterns of local recurrence. Diseases of the colon and rectum. 2004;47:44-7.

Keating JP. Sexual function after rectal excision. ANZ journal of surgery. 2004;74:248-59.

Keating J, Lolohea S and Kenwright D. Pathology reporting of rectal cancer: a national audit. The New Zealand medical journal. 2003;116:U514.

Keating J, Pater P, Lolohea S and Wickremesekera K. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? The New Zealand medical journal. 2003;116:U437.

Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Crnogorac-Jurcevic T, Buechler MW, Friess H, Neoptolemos JP, Pennington SR and Costello E. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics. 2003;3:1988-2001.

Connolly AB, Frizelle FA, Keating JP, Lynch AC, Thompson-Fawcett MW and Robertson GM. Review of developments in colorectal surgery in New Zealand. The New Zealand medical journal. 2002;115:262-5.

Magee CJ, Shekouh A, Ghaneh P and Neoptolemos JP. Update on pancreatic cancer. Hospital medicine (London, England : 1998). 2002;63:200-6.

Bokey EL, Moore JW, Keating JP, Zelas P, Chapuis PH and Newland RC. Laparoscopic resection of the colon and rectum for cancer. The British journal of surgery. 1997;84:822-5.

Back to top